Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis
PMID: 25805947
Source: World J Gastroenterol
Publication date:
2025-07-24
Year:
2015
Abstract
Five-amino salicylic acids are recommended for use in the management of inflammatory bowel disease, cardiac complications are a rare although recognised phenomenon. This report aims to highlight this serious but rare adverse reaction. We report here a case of a young man presenting with cardiogenic shock in the context of recent mesalazine treatment in severe ulcerative colitis.